Top

Journal of Orthopaedic Surgery and Research

Published in:

Open Access 01-12-2015 | Research article

Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder

Authors: Wataru Saito, Kentaro Uchida, Osamu Matsushita, Gen Inoue, Hiroyuki Sekiguchi, Jun Aikawa, Hisako Fujimaki, Masashi Takaso

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2015

Abstract

Background

To repair fractures with large bone defects or gaps, demineralized allogenic bone matrix (DBM) is often applied to the fracture site. However, studies have shown that the use of DBM alone has limited efficacy for repairing fractures. In the present study, we developed an allogenic demineralized bone powder (DBP) with basic fibroblast-derived growth factor containing a polycystic kidney disease (PKD) domain and collagen-binding domain (CBD) from Clostridium histolyticum collagenase (ColH) and investigated the stimulatory effects of bFGF-PKD-CBD combined with allogenic DBP on bone growth in a mouse femur fracture model.

Methods

DBP mixed with either phosphate-buffered saline (PBS) (DBP/PBS), 0.58 nmol basic fibroblast growth factor (bFGF) (0.58 nmol DBP/bFGF), 0.058 nmol bFGF-PKD-CBD (0.058 nmol DBP/bFGF-PKD-CBD), or 0.58 nmol bFGF-PKD-CBD (0.58 nmol DBP/bFGF-PKD-CBD) was grafted into fracture sites.

Results

bFGF-PKD-CBD/DBP composite accelerates callus formation in a bone fracture model in mice and clearly showed that the composite also increases bone mineral density at fracture sites compared to bFGF/DBP. In addition, bFGF-PKD-CBD/DBP increased callus volume and bone mineral content to similar levels in fractures treated with a tenfold higher amount of bFGF at 4 weeks.

Conclusions

Our results suggest that bFGF-PKD-CBD/DBP may be useful for promoting fracture healing in the clinical setting.

Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002;84-A:454–64.PubMed

Heckman JD, Sarasohn-Kahn J. The economics of treating tibia fractures. The cost of delayed unions. Bull Hosp Jt Dis. 1997;56:63–72.PubMed

Rose FR, Oreffo RO. Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun. 2002;292:1–7.CrossRefPubMed

Ludwig SC, Boden SD. Osteoinductive bone graft substitutes for spinal fusion: a basic science summary. Orthop Clin North Am. 1999;30:635–45.CrossRefPubMed

Peel SA, Hu ZM, Clokie CM. In search of the ideal bone morphogenetic protein delivery system: in vitro studies on demineralized bone matrix, purified, and recombinant bone morphogenetic protein. J Craniofac Surg. 2003;14:284–91.CrossRefPubMed

Tiedeman JJ, Garvin KL, Kile TA, Connolly JF. The role of a composite, demineralized bone matrix and bone marrow in the treatment of osseous defects. Orthopedics. 1995;18:1153–8.PubMed

Chen B, Lin H, Wang J, Zhao Y, Wang B, Zhao W, et al. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials. 2007;28:1027–35.CrossRefPubMed

Kale AA, Di Cesare PE. Osteoinductive agents. Basic science and clinical applications. Am J Orthop (Belle Mead NJ). 1995;24:752–61.

Friedlaender GE. OP-1 clinical studies. J Bone Joint Surg Am. 2001;83-A Suppl 1:S160–1.PubMed

10.

Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83-A Suppl 1:S151–8.PubMed

11.

Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84-A:2123–34.PubMed

12.

Kawaguchi H, Oka H, Jingushi S, Izumi T, Fukunaga M, Sato K, et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebo-controlled trial. J Bone Miner Res. 2010;25:2735–43.CrossRefPubMed

13.

Kigami R, Sato S, Tsuchiya N, Yoshimakai T, Arai Y, Ito K. FGF-2 angiogenesis in bone regeneration within critical-sized bone defects in rat calvaria. Implant Dent. 2013;22:422–7.CrossRefPubMed

14.

Lai RF, Zhou ZY, Chen T. Accelerating bone generation and bone mineralization in the interparietal sutures of rats using an rhBMP-2/ACS composite after rapid expansion. Exp Anim. 2013;62:189–96.CrossRefPubMedCentralPubMed

15.

Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res. 2001;49:532–42.CrossRefPubMed

16.

Unger EF, Goncalves L, Epstein SE, Chew EY, Trapnell CB, Cannon III RO, et al. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am J Cardiol. 2000;85:1414–9.CrossRefPubMed

17.

Nishi N, Matsushita O, Yuube K, Miyanaka H, Okabe A, Wada F. Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain. Proc Natl Acad Sci U S A. 1998;95:7018–23.CrossRefPubMedCentralPubMed

18.

Uchida K, Matsushita O, Naruse K, Mima T, Nishi N, Hattori S, et al. Acceleration of periosteal bone formation by human basic fibroblast growth factor containing a collagen-binding domain from Clostridium histolyticum collagenase. J Biomed Mater Res A. 2014;102:1737–43.CrossRefPubMedCentralPubMed

19.

Saito W, Uchida K, Ueno M, Matsushita O, Inoue G, Nishi N, et al. Acceleration of bone formation during fracture healing by injectable collagen powder and human basic fibroblast growth factor containing a collagen-binding domain from Clostridium histolyticum collagenase. J Biomed Mater Res A. 2014;102:3049–55.CrossRefPubMed

20.

Katano M, Naruse K, Uchida K, Mikuni-Takagaki Y, Takaso M, Itoman M, et al. Low intensity pulsed ultrasound accelerates delayed healing process by reducing the time required for the completion of endochondral ossification in the aged mouse femur fracture model. Exp Anim. 2011;60:385–95.CrossRefPubMed

21.

Uchida K, Urabe K, Naruse K, Kozai Y, Onuma K, Mikuni-Takagaki Y, et al. Differential age-related bone architecture changes between female and male STR/Ort mice. Exp Anim. 2012;61:59–66.CrossRefPubMed

22.

Tuli SM, Singh AD. The osteoninductive property of decalcified bone matrix. An experimental study. J Bone Joint Surg (Br). 1978;60:116–23.

23.

Wittbjer J, Palmer B, Rohlin M, Thorngren KG. Osteogenetic activity in composite grafts of demineralized compact bone and marrow. Clin Orthop Relat Res. 1983. 229–238.

24.

Aspenberg P, Thorngren KG, Lohmander LS. Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats. Acta Orthop Scand. 1991;62:481–4.CrossRefPubMed

25.

Lu M, Rabie AB. The effect of demineralized intramembranous bone matrix and basic fibroblast growth factor on the healing of allogeneic intramembranous bone grafts in the rabbit. Arch Oral Biol. 2002;47:831–41.CrossRefPubMed

26.

Wang L, Huang Y, Pan K, Jiang X, Liu C. Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation. Ann Biomed Eng. 2010;38:77–87.CrossRefPubMed

27.

Akita S, Fukui M, Nakagawa H, Fujii T, Akino K. Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen. 2004;12:252–9.CrossRefPubMed

28.

Su J, Xu H, Sun J, Gong X, Zhao H. Dual delivery of BMP-2 and bFGF from a new nano-composite scaffold, loaded with vascular stents for large-size mandibular defect regeneration. Int J Mol Sci. 2013;14:12714–28.CrossRefPubMedCentralPubMed

29.

Wang H, Zou Q, Boerman OC, Nijhuis AW, Jansen JA, Li Y, et al. Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo. J Control Release. 2013;166:172–81.CrossRefPubMed

Title: Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder
Authors: Wataru Saito
Kentaro Uchida
Osamu Matsushita
Gen Inoue
Hiroyuki Sekiguchi
Jun Aikawa
Hisako Fujimaki
Masashi Takaso
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Journal of Orthopaedic Surgery and Research / Issue 1/2015
Electronic ISSN: 1749-799X
DOI: https://doi.org/10.1186/s13018-015-0201-0

At a glance: The STEP trials

Springer Medicine

Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Effects of knee position on blood loss following total knee arthroplasty: a randomized, controlled study

A study on the cervical spondylotic myelopathy treated by anterior cervical diskectomy and fusion in accordance with Modic changes with a 2-year minimum follow-up

A biomechanical comparison between cortical bone trajectory fixation and pedicle screw fixation

Improved femoral component rotation in advanced genu valgum deformity using computer-assisted measured resection total knee arthroplasty

Clinical outcomes of allograft with locking compression plates for elderly four-part proximal humerus fractures

Debridement, internal fixation, and reconstruction using titanium mesh for the surgical treatment of thoracic and lumbar spinal tuberculosis via a posterior-only approach: a 4-year follow-up of 28 patients